- Current treatment of chronic myeloid leukemia - tyrosinkinas inhibitors.2012 | First Faculty of Medicine
- Complex chromosomal rearrangements in patients with chronic myeloid leukemia (CML)Publication without faculty affiliation
- Comparison of cytogenetic and molecular genetic methods in patients in chronic phase of chronic myeloid leukemia (CML) treated with imatinibe mesylatePublication without faculty affiliation
- Possible discontinuation of treatment by tyrosine kinase inhibitors in patients with chronic myeloid leukemia and concept of treatment-free remission2017 | Publication without faculty affiliation
- Statistical Analysis of Competing Risks: Overall Survival in a Group of Chronic Myeloid Leukemia Patients2011 | First Faculty of Medicine
- Incidence of second malignancies during treatment of chronic myeloid leukemia with tyrosine kinase inhibitors in the Czech Republic and Slovakia2011 | Faculty of Medicine in Hradec Králové
- N-terminally truncated WT1 variant (sWT1) is expressed at very low levels in acute myeloid leukemia and advanced phases of chronic myeloid leukemia2012 | Faculty of Science
- Gene expression profiles of two accelerations in a CML patient2006 | Central Library of Charles University
- Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with Imatinib mesylate for chronic or accelerated disease phase2004 | Publication without faculty affiliation
- Role of Epigenetics in Chronic Myeloid Leukemia2013 | First Faculty of Medicine
- Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy2018 | First Faculty of Medicine
- Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic2006 | Faculty of Medicine in Hradec Králové
- Do transcriptionally silent BCR-ABL cells persist in CML patients in molecular remission after stem cell transplantation?2001 | Central Library of Charles University, Second Faculty of Medicine
- Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic2006 | First Faculty of Medicine
- Dasatinib as first line therapy in chronic myeloid leukaemia2011 | Faculty of Medicine in Hradec Králové
- Chronic myeloid leukemia and pregnancy2017 | First Faculty of Medicine
- Disease status in patients with chronic myeloid leukemia is better characterized by BCR-ABL/BCR transcript ratio than by BCR-ABL transcript level, which may suggest a role of normal BCR gene in the disease pathogenesis2005 | Central Library of Charles University
- BCR-ABL mutation analysis allows to provide "tailors therapy" for CML patients resistant to imatinib2010 | Faculty of Medicine in Hradec Králové
- Expression of genes encoding centrosomal proteins and the humoral response against these proteins in chronic myeloid leukemia2017 | Faculty of Science
- Intracellular Cytokines Produced by Stimulated CD3+Cells from Chronic Myeloid Leukemia Patients2017 | Publication without faculty affiliation
- Sequential cytogenetic study of patients after bone marrow transplantation1994 | Second Faculty of Medicine
- Current survival measures reliably reflect modern sequential treatment in CML: Correlation with prognostic stratifications2013 | Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Discontinuation of biological therapy with tyrosine kinase inhibitors in chronic myeloid leukemia patients2014 | Faculty of Medicine in Pilsen
- Interferon-alpha Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients2016 | Faculty of Science, First Faculty of Medicine, Third Faculty of Medicine
- Termination of the treatment in chronic myeloid leukemia - possi bility of stopping the tyrosine kinase inhibitors2017 | First Faculty of Medicine
- Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells2021 | First Faculty of Medicine
- Somatic Mutations in Oncogenes Are in Chronic Myeloid Leukemia Acquired De Novo via Deregulated Base-Excision Repair and Alternative Non-Homologous End Joining2021 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
- Expression of four major WT1 splicing variants in acute and chronic myeloid leukemia patients analyzed by newly developed four real-time RT PCRs2012 | Faculty of Science
- Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia patients - worldwide battlefield2015 | Faculty of Medicine in Pilsen
- Kynurenine and uric acid levels in chronic myeloid leukemia patients2015 | First Faculty of Medicine, Faculty of Pharmacy in Hradec Králové